Type-I hyperlipoproteinemia, also known as familial hyperchylomicronemia, is a rare inherited disorder characterized by an elevated level of chylomicrons in the blood. This condition is caused by a deficiency in the enzyme lipoprotein lipase or the presence of a defective apolipoprotein C-II, both of which play critical roles in the breakdown of triglycerides carried by chylomicrons.
Pathophysiology:
- Under normal conditions, dietary fats are packaged into chylomicrons in the intestines, which then enter the bloodstream.
- Lipoprotein lipase, activated by apolipoprotein C-II, breaks down the triglycerides in chylomicrons into free fatty acids and glycerol for energy use or storage.
- In type-I hyperlipoproteinemia, due to the enzyme deficiency or defect in the activating protein, chylomicrons are not broken down effectively and accumulate in the bloodstream.
Clinical Features:
- Marked hypertriglyceridemia due to elevated chylomicrons.
- Presence of eruptive xanthomas, hepatosplenomegaly, and lipemia retinalis.
- Presents often in childhood with abdominal pain due to pancreatitis.
Diagnosis:
- Elevated plasma triglyceride levels.
- Laboratory tests revealing the accumulation of chylomicrons.
- Genetic testing may confirm mutations causing the enzyme deficiency.
Treatment:
- Low-fat diet to minimize chylomicron formation.
- Management of complications such as pancreatitis.
Conclusion:Type-I hyperlipoproteinemia is characterized by elevated chylomicrons. This condition results from impaired clearance of chylomicrons due to enzyme deficiencies or defects.